Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.
Topline: Taxpayers spent $74.5 million to help develop the prostate cancer-fighting drug Xtandi, but its sky-high sticker ...
Nationally, about 208 Black men per 100,000 died from cancer, as opposed to 179 per 100,000 white men, the study said. About ...
Researchers from Rice University and Vanderbilt University have made significant advancements in the fight against prostate ...
Cancer deaths among Black men and women in the United States have declined during the past decade in the United States, a new American Cancer Society report says.
The FDA has granted fast track status to 67Cu-SAR-bisPSMA for metastatic prostate cancer that is resistant to hormone therapy ...
Despite considerable efforts to improve the quality of end-of-life care in the United States, a new retrospective study led ...